# Silencing a liver gene may prevent brain damage from rare metabolic disease

> Duke University researchers report preclinical success with a liver-targeted siRNA therapy that silences a lysine-breakdown gene in glutaric aciduria type I (GA1), a rare inherited metabolic disorder. In mice, the treatment kept adult models alive and improved survival of treated neonatal models, even on high-protein diets. The study was published in Science Translational Medicine.

- Date: 2026-11-18 · published 2026-11-18T21:12:12.442Z
- Category: report · region US · magnitude low
- Page: https://feedsoft.ai/events/107212-silencing-a-liver-gene-may-prevent-brain-damage-from-rare-metabolic-disease
- Commodities: [Lysine](https://feedsoft.ai/c/LYSINE.md)

## Why it matters

This is a human health and biomedical research story with no link to feed, grain or oilseed supply, demand or prices.

## Sources

- medicalxpress.com: https://medicalxpress.com/news/2026-11-silencing-liver-gene-brain-rare.html

---
Data from Feedsoft AI (https://feedsoft.ai/). For information only; not investment advice.
